Enter assignee name

% Expired Patents = 37.5

EPO Patents = 2

Trademarks = 3

Forward Citations = 18

Loading Chart...

8 inventors (with patents filed for the assignee):

Robert J Rodriguez (8 out of 15 patents)

Robert G L Shorr (5 out of 16 patents)

Rajinder Bhasin (5 out of 8 patents)

4. Lakmal Boteju (3 out of 6 patents)

5. Thomas Kwok (3 out of 7 patents)

6. James Marecek (3 out of 3 patents)

7. Paul M Bingham (3 out of 7 patents)

8. Robert G Shorr (3 out of 34 patents)

9. Lakmal W Boteju (1 patent)

10. Robert Rodriguez (0 patent)

8 patents: Sort by Forward Citations

1. 11065335 - Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof (2021-07-20),

2. 10526357 - Pharmaceutical compounds (2020-01-07),

3. 10450337 - Pharmaceutical compounds (2019-10-22),

4. 10391177 - Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid (2019-08-27),

5. 10179796 - Pharmaceutical compounds (2019-01-15),

6. 10098955 - Pharmaceutical formulations containing lipoic acid derivatives (2018-10-16),

7. 9872845 - Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivative (2018-01-23),

8. 9839691 - Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative (2017-12-12),

Rafael Pharmaceuticals, Inc. is a clinical-stage, precision oncology therapeutics company targeting cancer metabolism. Their lead product candidate, CPI-613, is being evaluated in multiple Phase 1, 2, and 3 clinical trials for the treatment of various cancers. With a focus on developing innovative therapies for hard-to-treat cancers, Rafael Pharmaceuticals is committed to improving patient outcomes and quality of life.

Profile summary based on public USPTO records.